Contact
Anna L. Barcelos
MarCom Manager
+1 508-544-7000, Ext. 233
[email protected]

TEKCEL APPOINTS DR. FRANK CRAIG TO BOARD OF DIRECTORS

Hopkinton, Massachusetts, USA, May 27, 2003 -- TekCel, a leading innovator of discovery process management productivity tools for life science research, is pleased to announce that Dr. Frank Craig has joined the company's Board of Directors.

Chris McNary, President and CEO of TekCel, said, "We are more than pleased to have someone with Dr. Craig's extensive scientific background and industry affiliations as a member of the Board of Directors. His extensive business experience in developing and commercializing novel life science technologies will be instrumental in further expanding our product offerings as we move forward."

"I am excited about the prospect of helping TekCel build on its recent success," said Dr. Craig. "TekCel's sample management systems address an unmet need in drug discovery and have been shown to improve compound integrity and process efficiency across a diverse client base, ranging from international pharmaceutical to emerging biotech companies. This success provides a strong foundation for future growth, and I look forward to working with the company."

Dr. Craig has 10 years of international management experience in the areas of research and development and business development. He has worked for both biotechnology start-ups and global companies and has comprehensive knowledge of the life sciences industry. Currently, Dr. Craig has his own management and consultancy business, which has an international client base in the biotechnology sector. Previously, he held various positions with Amersham Biosciences, including Vice President of Research and Development and as a member of an executive team managing a global business unit that generated $160 million in annual revenue. Dr. Craig also co-founded Aurora Biosciences Corporation (purchased by Vertex in 2001), a firm that pioneered ultra high throughput screening (uHTS), and worked for GlaxoSmithKline in new lead discovery. He has a Ph.D. in Microbiology from the University of Glasgow and an MBA from Warwick Business School.

ABOUT TEKCEL
Founded in 1998 and privately held, TekCel is a leading innovator of drug discovery process management productivity tools. TekCel's solutions yield dramatic improvements in efficiency and effectiveness by automating manual processes, integrating applications and maximizing process controls to ensure biological and chemical sample integrity and resulting data fidelity. TekCel's modular, scalable family of products includes sample management automation, liquid handling, software and proprietary consumables addressing the researchers' needs from archive compound storage through screening result.

For more information, contact TekCel, Inc., 103 South Street, Hopkinton, MA 01748. Tel: 800-310-5866 (in US). Email: [email protected]. Website: www.tekcel.com. European Office: 14 St. George's Close, Brampton, Cambridge, PE28 4US, UK. Tel/Fax: +44 (0) 1480 431900.

###